| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Roger J Colbran | |
| Ariel Y Deutch | |||
| Danny J Winder | |||
| P2860 | cites work | Multivalent interactions of calcium/calmodulin-dependent protein kinase II with the postsynaptic density proteins NR2B, densin-180, and alpha-actinin-2 | Q28569375 |
| Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism | Q28579756 | ||
| Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice | Q28590689 | ||
| A gene expression atlas of the central nervous system based on bacterial artificial chromosomes | Q29617753 | ||
| Learning induces long-term potentiation in the hippocampus | Q29619482 | ||
| The role of the basal ganglia in habit formation | Q29619829 | ||
| Evidence of a breakdown of corticostriatal connections in Parkinson's disease. | Q33214147 | ||
| Dendritic spines shaped by synaptic activity | Q34085494 | ||
| Dopaminergic control of synaptic plasticity in the dorsal striatum | Q34206258 | ||
| Roles of serine/threonine phosphatases in hippocampal synaptic plasticity. | Q34297126 | ||
| Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. | Q34521936 | ||
| Dopamine-dependent synaptic plasticity in striatum during in vivo development | Q34658296 | ||
| Targeting of calcium/calmodulin-dependent protein kinase II. | Q35599584 | ||
| DARPP-32: an integrator of neurotransmission | Q35639141 | ||
| Calcium channel blockers and beta-blockers in relation to Parkinson's disease | Q35845076 | ||
| The role of calmodulin as a signal integrator for synaptic plasticity | Q36085639 | ||
| Cortical regulation of dopamine depletion-induced dendritic spine loss in striatal medium spiny neurons | Q36169973 | ||
| In vivo activity-dependent plasticity at cortico-striatal connections: evidence for physiological long-term potentiation | Q36247620 | ||
| Brain plasticity and mental processes: Cajal again | Q36599933 | ||
| Calcium/calmodulin-dependent protein kinase II (CaMKII) localization acts in concert with substrate targeting to create spatial restriction for phosphorylation | Q40483909 | ||
| Dendritic spines for neuroprotection: a hypothesis | Q40964680 | ||
| Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression | Q41661848 | ||
| Dopamine modulates release from corticostriatal terminals. | Q42469821 | ||
| Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 | ||
| D2 dopamine receptors in striatal medium spiny neurons reduce L-type Ca2+ currents and excitability via a novel PLC[beta]1-IP3-calcineurin-signaling cascade. | Q43513203 | ||
| Postsynaptic endocannabinoid release is critical to long-term depression in the striatum | Q43971441 | ||
| Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia | Q44383212 | ||
| A CaMKII-NeuroD signaling pathway specifies dendritic morphogenesis. | Q44740477 | ||
| Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism. | Q44931344 | ||
| A potassium channel blocker induces a long-lasting enhancement of corticostriatal responses. | Q45253609 | ||
| Regulation of F-actin stability in dendritic spines by glutamate receptors and calcineurin. | Q46290655 | ||
| Differential modulation of Ca2+/calmodulin-dependent protein kinase II activity by regulated interactions with N-methyl-D-aspartate receptor NR2B subunits and alpha-actinin | Q46711229 | ||
| Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. | Q46896175 | ||
| Gene expression nervous system atlas (GENSAT). | Q47683080 | ||
| Enhancement of N-methyl-D-aspartate (NMDA) immunoreactivity in residual dendritic spines in the caudate-putamen nucleus after chronic haloperidol administration | Q48152517 | ||
| Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits | Q48271271 | ||
| alphaCaMKII Is essential for cerebellar LTD and motor learning | Q48418590 | ||
| Stabilization of dendritic arbor structure in vivo by CaMKII. | Q48553819 | ||
| Differential inactivation of postsynaptic density-associated and soluble Ca2+/calmodulin-dependent protein kinase II by protein phosphatases 1 and 2A. | Q48723256 | ||
| Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease | Q49069694 | ||
| Regional and postnatal heterogeneity of activity-dependent long-term changes in synaptic efficacy in the dorsal striatum. | Q52165392 | ||
| Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age | Q69262673 | ||
| Short- and long-term synaptic depression in rat neostriatum | Q72665515 | ||
| Sensitivity of CaM kinase II to the frequency of Ca2+ oscillations | Q74016176 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| striatum | Q1319792 | ||
| P304 | page(s) | S251-8 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Parkinsonism and Related Disorders | Q15762600 |
| P1476 | title | Striatal plasticity and medium spiny neuron dendritic remodeling in parkinsonism | |
| P478 | volume | 13 Suppl 3 |
| Q33729745 | A neurocomputational method for fully automated 3D dendritic spine detection and segmentation of medium-sized spiny neurons |
| Q35607243 | Adenosine A2a receptor antagonists attenuate striatal adaptations following dopamine depletion. |
| Q35141359 | An embryonic culture system for the investigation of striatal medium spiny neuron dendritic spine development and plasticity |
| Q39427212 | Are the Symptoms of Parkinsonism Cortical in Origin? |
| Q30010598 | Brain mechanisms of acoustic communication in humans and nonhuman primates: an evolutionary perspective |
| Q34116613 | Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss |
| Q53446566 | Differential Synaptic Remodeling by Dopamine in Direct and Indirect Striatal Projection Neurons in Pitx3-/- Mice, a Genetic Model of Parkinson's Disease. |
| Q37185190 | Differential striatal spine pathology in Parkinson's disease and cocaine addiction: a key role of dopamine? |
| Q30498354 | Differential structural plasticity of corticostriatal and thalamostriatal axo-spinous synapses in MPTP-treated Parkinsonian monkeys |
| Q38837604 | Early synaptic dysfunction in Parkinson's disease: Insights from animal models. |
| Q35898412 | Endocannabinoid-dopamine interactions in striatal synaptic plasticity |
| Q28397666 | Extracerebellar role for Cerebellin1: modulation of dendritic spine density and synapses in striatal medium spiny neurons |
| Q28391734 | Gender and manganese exposure interactions on mouse striatal neuron morphology |
| Q37584846 | How voltage-gated calcium channels gate forms of homeostatic synaptic plasticity |
| Q64781304 | Increase in Glutamatergic Terminals in the Striatum Following Dopamine Depletion in a Rat Model of Parkinson's Disease |
| Q37344222 | L-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia |
| Q27002626 | Levodopa-induced plasticity: a double-edged sword in Parkinson's disease? |
| Q38766091 | Loss and remodeling of striatal dendritic spines in Parkinson's disease: from homeostasis to maladaptive plasticity? |
| Q40817289 | MEF-2 regulates activity-dependent spine loss in striatopallidal medium spiny neurons. |
| Q49149998 | Melatonin synergizes with low doses of L-DOPA to improve dendritic spine density in the mouse striatum in experimental Parkinsonism |
| Q45340134 | Methods for treating neurological conditions (WO2011159945). |
| Q28505365 | Mice Lacking GPR88 Show Motor Deficit, Improved Spatial Learning, and Low Anxiety Reversed by Delta Opioid Antagonist |
| Q41152831 | Modification of spectral features by nonhuman primates |
| Q36367283 | Modulation of striatal projection systems by dopamine |
| Q26781619 | Morphological changes of glutamatergic synapses in animal models of Parkinson's disease |
| Q33791589 | Morphometric analysis in neurodegenerative disorders |
| Q92933018 | Neuregulin-4 Is Required for the Growth and Elaboration of Striatal Medium Spiny Neuron Dendrites |
| Q35176103 | Neuroglial plasticity at striatal glutamatergic synapses in Parkinson's disease |
| Q37955871 | Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts |
| Q31020342 | Neuroregeneration in neurodegenerative disorders |
| Q33522039 | Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson's disease |
| Q37377815 | Oxidative damage and neurodegeneration in manganese-induced neurotoxicity |
| Q41892807 | Procedural-based category learning in patients with Parkinson's disease: impact of category number and category continuity |
| Q35490451 | Protective effects of antioxidants and anti-inflammatory agents against manganese-induced oxidative damage and neuronal injury |
| Q28255428 | STEP61 is a substrate of the E3 ligase parkin and is upregulated in Parkinson's disease |
| Q34154154 | Signaling pathways controlling the phosphorylation state of WAVE1, a regulator of actin polymerization |
| Q35871006 | Striatal atrophy and dendritic alterations in a knock-in mouse model of Huntington's disease |
| Q34416203 | Striatal spine plasticity in Parkinson's disease |
| Q34790601 | Striatal spine plasticity in Parkinson's disease: pathological or not? |
| Q52371217 | Synaptic plasticity and levodopa-induced dyskinesia: electrophysiological and structural abnormalities. |
| Q31104394 | The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment |
| Q38182660 | The pathomechanisms underlying Parkinson's disease |
| Q42505593 | Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats. |
Search more.